ALLO- Allogene Therapeutics, Inc.

Name: Allogene Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Allogene Therapeutics, Inc. (ALLO) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 23 sells. ALLO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Parker Geoffrey M.	1.28M	$2.97M	-
VP	Beneski Benjamin MacHinas	217.7K	$507.3K	-
Dir	Sato Vicki L	144.4K	$336.5K	-
Dir	Mayo Stephen	95.4K	$222.3K	-
Dir	Witte Owen N.	95.4K	$222.3K	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jun 22, 2020	Tpg Group Holdings (sbs) Advisors, Inc.86	10% Owner	Sell	314,792	$42.50	$13,379,622.58	-0.4%
Jun 17, 2020	Tpg Group Holdings (sbs) Advisors, Inc.86	10% Owner	Sell	390,984	$42.18	$16,491,045.84	-0.6%
Jun 4, 2020	Belldegrun Arie	Director	Buy	146,382	$47.00	$6,879,954.00	+8.7%
Jun 4, 2020	Tpg Group Holdings (sbs) Advisors, Inc.86	10% Owner	Sell	489,220	$47.40	$23,188,151.85	-0.8%
Mar 16, 2020	Schmidt Eric Thomas	Chief Financial Officer	Sell	5,450	$19.73	$107,507.86	-5.4%
Mar 16, 2020	Moore Alison69	Chief Technical Officer	Sell	3,750	$19.19	$71,980.13	-5.6%
Mar 16, 2020	Chang David D56	President And CEO	Sell	20,335	$19.31	$392,615.23	-0.5%
Sep 18, 2019	Moore Alison69	Chief Technical Officer	Sale+OE	48,827	$32.11	$1,567,666.24	-19.8%
Jul 30, 2019	Moore Alison69	Chief Technical Officer	Sale+OE	48,827	$29.44	$1,437,602.68	-19.9%
Jun 3, 2019	Moore Alison69	Chief Technical Officer	Sale+OE	48,828	$26.76	$1,306,774.34	-38.9%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC